Naproxen in juvenile chronic polyarthritis.

Area of Science:

• Pediatric Rheumatology
• Pharmacology

Background:

• Juvenile chronic arthritis requires effective and safe anti-inflammatory treatments.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used, but side effects are a concern.

Purpose of the Study:

• To compare the efficacy and gastrointestinal tolerability of naproxen versus aspirin in children with juvenile chronic polyarthritis.
• To assess the long-term safety and efficacy of naproxen in managing juvenile chronic arthritis.

Main Methods:

• A comparative study involving children diagnosed with juvenile chronic polyarthritis.
• Dosage comparison: naproxen (10 mg/kg) against aspirin (80 mg/kg).
• A long-term tolerance study of naproxen up to 12 months.

Main Results:

• Naproxen demonstrated comparable efficacy to aspirin in treating juvenile chronic polyarthritis.
• Naproxen exhibited potentially fewer gastrointestinal side effects than aspirin.
• Long-term use (up to 12 months) confirmed naproxen's satisfactory tolerability.

Conclusions:

• Naproxen is an effective NSAID for managing juvenile chronic arthritis in children.
• Naproxen offers a favorable safety profile, particularly regarding gastrointestinal tolerability, compared to aspirin.